These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32978364)

  • 1. SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
    Zurita MF; Iglesias Arreaga A; Luzuriaga Chavez AA; Zurita L
    Am J Case Rep; 2020 Sep; 21():e927304. PubMed ID: 32978364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
    He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
    Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.
    Ramirez GA; Gerosa M; Beretta L; Bellocchi C; Argolini LM; Moroni L; Della Torre E; Artusi C; Nicolosi S; Caporali R; Bozzolo EP; Dagna L;
    Semin Arthritis Rheum; 2020 Oct; 50(5):1150-1157. PubMed ID: 32927376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
    Bozzalla Cassione E; Zanframundo G; Biglia A; Codullo V; Montecucco C; Cavagna L
    Ann Rheum Dis; 2020 Oct; 79(10):1382-1383. PubMed ID: 32398281
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    Peschken CA
    J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
    [No Abstract]   [Full Text] [Related]  

  • 10. A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.
    Moniuszko-Malinowska A; Czupryna P; Boczkowska-Radziwon B; Wasiluk T; Borawski K; Dunaj J; Bujno M; Radziwon P; Rutkowski K; Pancewicz S
    Am J Case Rep; 2020 Sep; 21():e927662. PubMed ID: 32991573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial.
    Pirjani R; Soori T; Dehpour AR; Sepidarkish M; Moini A; Shizarpour A; Mohammad Jafari R
    Trials; 2020 Jun; 21(1):467. PubMed ID: 32493447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral exanthema as manifestation of SARS-CoV-2 infection: A case report.
    Iancu GM; Solomon A; Birlutiu V
    Medicine (Baltimore); 2020 Aug; 99(35):e21810. PubMed ID: 32871902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma.
    Moore JL; Ganapathiraju PV; Kurtz CP; Wainscoat B
    Am J Case Rep; 2020 Oct; 21():e927812. PubMed ID: 33009361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
    Kauv J; Lê MP; Veyrier M; Le Hingrat Q; Visseaux B; Massias L; Chauveheid MP; Descamps D; Ghosn J; Peytavin G
    J Antimicrob Chemother; 2020 Sep; 75(9):2706-2707. PubMed ID: 32457980
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
    Konig MF; Kim AH; Scheetz MH; Graef ER; Liew JW; Simard J; Machado PM; Gianfrancesco M; Yazdany J; Langguth D; Robinson PC;
    Ann Rheum Dis; 2020 Oct; 79(10):1386-1388. PubMed ID: 32381561
    [No Abstract]   [Full Text] [Related]  

  • 17. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed Diagnosis and Treatment of a Critically Ill Patient with Infective Endocarditis Due to a False-Positive Molecular Diagnostic Test for SARS-CoV-2.
    Schizas N; Michailidis T; Samiotis I; Patris V; Papakonstantinou K; Argiriou M; Dedeilias P
    Am J Case Rep; 2020 Sep; 21():e925931. PubMed ID: 32980852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of COVID-19 pandemic on SLE: beyond the risk of infection.
    Horisberger A; Moi L; Ribi C; Comte D
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32376774
    [No Abstract]   [Full Text] [Related]  

  • 20. Diarrhoea: An Atypical Presentation of COVID-19.
    Khan S; Ahmad Z; Khan F; Asif H; Zia-Ur-Rahman A
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):40-42. PubMed ID: 32723447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.